Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

MDZ

Mds (MDZ)

Mds

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:MDZ

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
30/07/2004	00h31	PR Newswire (US)	MDS Proteomics Announces Completion of Financial Reorganization and Name Change to Protana Inc.	NYSE:MDZ
30/07/2004	00h31	PR Newswire (US)	MDS Inc. Announces Completion of Proteomics Reorganization	NYSE:MDZ
28/07/2004	07h01	PR Newswire (US)	MDS Pharma Services Establishes Central Lab Testing Facility in Singapore	NYSE:MDZ
17/06/2004	15h00	PR Newswire (US)	MDS Inc. normal course issuer bid	NYSE:MDZ
17/06/2004	11h00	PR Newswire (US)	MDS Nordion to manufacture Molecular Insight's lead molecular imaging pharmaceutical	NYSE:MDZ
02/06/2004	15h01	PR Newswire (US)	Iconix Announces Chemogenomics Collaborative Relationship with AstraZeneca	NYSE:MDZ	Mds
02/06/2004	15h00	PR Newswire (US)	MDS Reports Second Quarter Fiscal 2004 Financial Results	NYSE:MDZ
01/06/2004	23h40	PR Newswire (US)	MDS Inc. Supports Proteomics New Business Plan and Financial Reorganization	NYSE:MDZ
01/06/2004	23h39	PR Newswire (US)	MDS Proteomics Announces New Business Plan and Financial Reorganization	NYSE:MDZ
06/05/2004	15h00	PR Newswire (US)	MDS Inc. Repositions Executive Management Team - Creates Chief Operating Officer Position	NYSE:MDZ
03/05/2004	15h51	PR Newswire (US)	MDS Inc. Announces Completion of Hemosol Transaction	NYSE:MDZ
14/04/2004	21h30	PR Newswire (US)	SOLVO and MDS Pharma Services Team Up to Offer ABC Transporter Assays	NYSE:MDZ
30/03/2004	13h00	PR Newswire (US)	MDS Nordion announces first North American sales of Raycell X-ray blood irradiator ideal for low volume facilities seeking to pr	NYSE:MDZ
16/03/2004	14h01	PR Newswire (US)	MDS Announces Sale of Laboratory Operations in New York and Georgia to LabCorp(R)	NYSE:MDZ
11/03/2004	15h02	PR Newswire (US)	MDS Sciex Signs Distribution Agreement with VWR for US and Canadian Market	NYSE:MDZ
09/03/2004	15h00	PR Newswire (US)	MDS Sciex announces ProteoSpin(TM) products	NYSE:MDZ
04/03/2004	14h00	PR Newswire (US)	MDS Reports First Quarter Fiscal 2004 Financial Results	NYSE:MDZ
02/03/2004	14h35	PR Newswire (US)	Lutetium und Rhenium von MDS Nordion jetzt kommerziell erhältlich	NYSE:MDZ	Mds
02/03/2004	14h32	PR Newswire (US)	MDS Nordion anuncia la disponibilidad comercial de lutetium y rhenium	NYSE:MDZ	Mds
02/03/2004	11h00	PR Newswire (US)	MDS Nordion announces commercial availability of lutetium, rhenium	NYSE:MDZ
02/03/2004	11h00	PR Newswire (US)	MDS Nordion announces commercial availability of lutetium, rhenium	NYSE:MDZ	Mds
14/02/2004	12h39	PR Newswire (US)	MDS Pharma Services nombra nueva directora local para una planta en Ginebra	NYSE:MDZ	Mds
14/02/2004	11h08	PR Newswire (US)	MDS Pharma Services nomme un nouveau chef de travaux pour son centre de Genève	NYSE:MDZ	Mds
14/02/2004	10h29	PR Newswire (US)	MDS Pharma Services ernennt neuen Betriebsdirektor für die Anlage in Genf	NYSE:MDZ	Mds
13/02/2004	22h00	PR Newswire (US)	MDS Pharma Services Names New Site Director for Facility in Geneva	NYSE:MDZ	Mds
13/02/2004	22h00	PR Newswire (US)	MDS Pharma Services Names New Site Director for Facility in Geneva	NYSE:MDZ	Mds
12/02/2004	17h55	PR Newswire (US)	Cohesive Technologies Inc. Announces Development, Sales, and Support Agreement with Applied Biosystems	NYSE:MDZ
12/02/2004	13h45	PR Newswire (US)	MDS Inc. to Benefit From Hemosol Tax Losses	NYSE:MDZ
06/02/2004	17h00	PR Newswire (US)	MDS Pharma Services Appoints General Manager for Late Stage Development	NYSE:MDZ	Mds
07/01/2004	15h00	PR Newswire (US)	MDS Inc. Appoints David Poirier as President, Enterprise Services	NYSE:MDZ

Showing the most relevant articles for your search:NYSE:MDZ

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Health Care Select Sector

BNP Paribas (QX)

Financial Select Sector

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen